Nationwide Fund Advisors’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-64,030
Closed -$1.11M 884
2017
Q3
$1.11M Buy
64,030
+2,835
+5% +$38.4K ﹤0.01% 1718
2017
Q2
$785K Sell
61,195
-2,216
-3% -$29.6K ﹤0.01% 1924
2017
Q1
$822K Sell
63,411
-4,586
-7% -$58K ﹤0.01% 1871
2016
Q4
$672K Sell
67,997
-3,289
-5% -$36K ﹤0.01% 1999
2016
Q3
$861K Hold
71,286
﹤0.01% 1877
2016
Q2
$615K Buy
71,286
+2,559
+4% +$25.3K ﹤0.01% 2040
2016
Q1
$651K Sell
68,727
-1,090
-2% -$10.3K ﹤0.01% 1946
2015
Q4
$1.21M Buy
69,817
+1,563
+2% +$24.9K 0.01% 1631
2015
Q3
$917K Sell
68,254
-510
-0.7% -$10.2K ﹤0.01% 1774
2015
Q2
$1.55M Sell
68,764
-6,969
-9% -$122K 0.01% 1588
2015
Q1
$1.08M Sell
75,733
-3,358
-4% -$48.4K ﹤0.01% 1846
2014
Q4
$763K Sell
79,091
-693
-0.9% -$6.16K ﹤0.01% 1946
2014
Q3
$726K Buy
79,784
+453
+0.6% +$4.31K ﹤0.01% 1998
2014
Q2
$784K Buy
79,331
+4,998
+7% +$42.4K ﹤0.01% 2025
2014
Q1
$944K Buy
74,333
+5,606
+8% +$83.2K ﹤0.01% 1757
2013
Q4
$1.03M Sell
68,727
-1,850
-3% -$23.8K ﹤0.01% 1854
2013
Q3
$779K Buy
70,577
+2,945
+4% +$24.5K ﹤0.01% 1977
2013
Q2
$537K Buy
+67,632
New +$431K ﹤0.01% 1985

Other funds holding HALO

Nationwide Fund Advisors's HALO Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Halozyme (HALO) in Q4 2017, closing a stake of 64,030 shares — an estimated $1.11M sold.

Nationwide Fund Advisors first reported a position in HALO in Q2 2013 and held it in 18 quarters. The position peaked at $1.55M in Q2 2015. 198 funds tracked by Wall St. Rank hold HALO as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Halozyme position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 64,030 Halozyme shares in Q4 2017, an estimated $1.11M.
  • Nationwide Fund Advisors first reported a position in Halozyme in Q2 2013 and held it in 18 quarters.
  • Nationwide Fund Advisors's Halozyme position peaked at $1.55M in Q2 2015.
  • 198 funds tracked by Wall St. Rank held Halozyme as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.